Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

The Blockade of CC Chemokine Receptor Type 1 Influences the Level of Nociceptive Factors and Enhances Opioid Analgesic Potency in a Rat Model of Neuropathic Pain.

Pawlik K, Piotrowska A, Kwiatkowski K, Ciapała K, Popiolek-Barczyk K, Makuch W, Mika J.

Immunology. 2020 Jan 9. doi: 10.1111/imm.13172. [Epub ahead of print]

PMID:
31919846
2.

Pharmacological Blockade of Spinal CXCL3/CXCR2 Signaling by NVP CXCR2 20, a Selective CXCR2 Antagonist, Reduces Neuropathic Pain Following Peripheral Nerve Injury.

Piotrowska A, Rojewska E, Pawlik K, Kreiner G, Ciechanowska A, Makuch W, Nalepa I, Mika J.

Front Immunol. 2019 Sep 26;10:2198. doi: 10.3389/fimmu.2019.02198. eCollection 2019.

3.

Functional characterization of a novel opioid, PZM21, and its effects on the behavioural responses to morphine.

Kudla L, Bugno R, Skupio U, Wiktorowska L, Solecki W, Wojtas A, Golembiowska K, Zádor F, Benyhe S, Buda S, Makuch W, Przewlocka B, Bojarski AJ, Przewlocki R.

Br J Pharmacol. 2019 Dec;176(23):4434-4445. doi: 10.1111/bph.14805. Epub 2019 Dec 8.

PMID:
31347704
4.

Chemokines CCL2 and CCL7, but not CCL12, play a significant role in the development of pain-related behavior and opioid-induced analgesia.

Kwiatkowski K, Popiolek-Barczyk K, Piotrowska A, Rojewska E, Ciapała K, Makuch W, Mika J.

Cytokine. 2019 Jul;119:202-213. doi: 10.1016/j.cyto.2019.03.007. Epub 2019 Apr 16.

PMID:
31003094
5.

Dataset of (±)-NBI-74330 (CXCR3 antagonist) influence on chemokines under neuropathic pain.

Piotrowska A, Rojewska E, Pawlik K, Kreiner G, Ciechanowska A, Makuch W, Mika J.

Data Brief. 2018 Oct 26;21:1145-1150. doi: 10.1016/j.dib.2018.10.091. eCollection 2018 Dec.

6.

Involvement of microglial cells in the antinociceptive effects of metamizol in a mouse model of neuropathic pain.

Zajaczkowska R, Popiolek-Barczyk K, Pilat D, Rojewska E, Makuch W, Wordliczek J, Mika J.

Pharmacol Biochem Behav. 2018 Dec;175:77-88. doi: 10.1016/j.pbb.2018.09.008. Epub 2018 Sep 26.

PMID:
30267794
7.

Zaprinast diminished pain and enhanced opioid analgesia in a rat neuropathic pain model.

Rojewska E, Piotrowska A, Jurga A, Makuch W, Mika J.

Eur J Pharmacol. 2018 Nov 15;839:21-32. doi: 10.1016/j.ejphar.2018.09.001. Epub 2018 Sep 10.

PMID:
30213497
8.

Pharmacological blockade of CXCR3 by (±)-NBI-74330 reduces neuropathic pain and enhances opioid effectiveness - Evidence from in vivo and in vitro studies.

Piotrowska A, Rojewska E, Pawlik K, Kreiner G, Ciechanowska A, Makuch W, Zychowska M, Mika J.

Biochim Biophys Acta Mol Basis Dis. 2018 Oct;1864(10):3418-3437. doi: 10.1016/j.bbadis.2018.07.032. Epub 2018 Aug 1.

9.

Pharmacological Inhibition of Indoleamine 2,3-Dioxygenase-2 and Kynurenine 3-Monooxygenase, Enzymes of the Kynurenine Pathway, Significantly Diminishes Neuropathic Pain in a Rat Model.

Rojewska E, Ciapała K, Piotrowska A, Makuch W, Mika J.

Front Pharmacol. 2018 Jul 11;9:724. doi: 10.3389/fphar.2018.00724. eCollection 2018.

10.

Lipopolysaccharide from Rhodobacter sphaeroides (TLR4 antagonist) attenuates hypersensitivity and modulates nociceptive factors.

Jurga AM, Rojewska E, Makuch W, Mika J.

Pharm Biol. 2018 Dec;56(1):275-286. doi: 10.1080/13880209.2018.1457061.

11.

Antinociceptive effects of novel histamine H3 and H4 receptor antagonists and their influence on morphine analgesia of neuropathic pain in the mouse.

Popiolek-Barczyk K, Łażewska D, Latacz G, Olejarz A, Makuch W, Stark H, Kieć-Kononowicz K, Mika J.

Br J Pharmacol. 2018 Jul;175(14):2897-2910. doi: 10.1111/bph.14185. Epub 2018 May 31.

12.

Biphalin, a Dimeric Enkephalin, Alleviates LPS-Induced Activation in Rat Primary Microglial Cultures in Opioid Receptor-Dependent and Receptor-Independent Manners.

Popiolek-Barczyk K, Piotrowska A, Makuch W, Mika J.

Neural Plast. 2017;2017:3829472. doi: 10.1155/2017/3829472. Epub 2017 May 10.

13.

Bifunctional opioid/nociceptin hybrid KGNOP1 effectively attenuates pain-related behaviour in a rat model of neuropathy.

Starnowska J, Guillemyn K, Makuch W, Mika J, Ballet S, Przewlocka B.

Eur J Pharm Sci. 2017 Jun 15;104:221-229. doi: 10.1016/j.ejps.2017.03.029. Epub 2017 Mar 24.

PMID:
28347772
14.

The RS504393 Influences the Level of Nociceptive Factors and Enhances Opioid Analgesic Potency in Neuropathic Rats.

Kwiatkowski K, Piotrowska A, Rojewska E, Makuch W, Mika J.

J Neuroimmune Pharmacol. 2017 Sep;12(3):402-419. doi: 10.1007/s11481-017-9729-6. Epub 2017 Mar 23.

15.

Blockade of P2X4 Receptors Inhibits Neuropathic Pain-Related Behavior by Preventing MMP-9 Activation and, Consequently, Pronociceptive Interleukin Release in a Rat Model.

Jurga AM, Piotrowska A, Makuch W, Przewlocka B, Mika J.

Front Pharmacol. 2017 Feb 16;8:48. doi: 10.3389/fphar.2017.00048. eCollection 2017.

16.

Dataset of botulinum toxin A influence on interleukins under neuropathy.

Zychowska M, Rojewska E, Makuch W, Luvisetto S, Pavone F, Marinelli S, Przewlocka B, Mika J.

Data Brief. 2016 Nov 15;9:1020-1023. eCollection 2016 Dec.

17.

Participation of pro- and anti-nociceptive interleukins in botulinum toxin A-induced analgesia in a rat model of neuropathic pain.

Zychowska M, Rojewska E, Makuch W, Luvisetto S, Pavone F, Marinelli S, Przewlocka B, Mika J.

Eur J Pharmacol. 2016 Nov 15;791:377-388. doi: 10.1016/j.ejphar.2016.09.019. Epub 2016 Sep 9.

PMID:
27619001
18.

Direct and indirect pharmacological modulation of CCL2/CCR2 pathway results in attenuation of neuropathic pain - In vivo and in vitro evidence.

Piotrowska A, Kwiatkowski K, Rojewska E, Slusarczyk J, Makuch W, Basta-Kaim A, Przewlocka B, Mika J.

J Neuroimmunol. 2016 Aug 15;297:9-19. doi: 10.1016/j.jneuroim.2016.04.017. Epub 2016 May 3.

PMID:
27397071
19.

The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain.

Malek N, Kostrzewa M, Makuch W, Pajak A, Kucharczyk M, Piscitelli F, Przewlocka B, Di Marzo V, Starowicz K.

Pharmacol Res. 2016 Sep;111:251-263. doi: 10.1016/j.phrs.2016.06.012. Epub 2016 Jun 17.

PMID:
27326920
20.

Maraviroc reduces neuropathic pain through polarization of microglia and astroglia - Evidence from in vivo and in vitro studies.

Piotrowska A, Kwiatkowski K, Rojewska E, Makuch W, Mika J.

Neuropharmacology. 2016 Sep;108:207-19. doi: 10.1016/j.neuropharm.2016.04.024. Epub 2016 Apr 23.

PMID:
27117708
21.

Blockade of Toll-Like Receptors (TLR2, TLR4) Attenuates Pain and Potentiates Buprenorphine Analgesia in a Rat Neuropathic Pain Model.

Jurga AM, Rojewska E, Piotrowska A, Makuch W, Pilat D, Przewlocka B, Mika J.

Neural Plast. 2016;2016:5238730. doi: 10.1155/2016/5238730. Epub 2015 Dec 29.

22.

Blockade of IL-18 signaling diminished neuropathic pain and enhanced the efficacy of morphine and buprenorphine.

Pilat D, Piotrowska A, Rojewska E, Jurga A, Ślusarczyk J, Makuch W, Basta-Kaim A, Przewlocka B, Mika J.

Mol Cell Neurosci. 2016 Mar;71:114-24. doi: 10.1016/j.mcn.2015.12.013. Epub 2016 Jan 5.

PMID:
26763728
23.

Treatment with a carbon monoxide-releasing molecule (CORM-2) inhibits neuropathic pain and enhances opioid effectiveness in rats.

Jurga AM, Piotrowska A, Starnowska J, Rojewska E, Makuch W, Mika J.

Pharmacol Rep. 2016 Feb;68(1):206-13. doi: 10.1016/j.pharep.2015.08.016. Epub 2015 Sep 11.

PMID:
26721375
24.

Dual Alleviation of Acute and Neuropathic Pain by Fused Opioid Agonist-Neurokinin 1 Antagonist Peptidomimetics.

Betti C, Starnowska J, Mika J, Dyniewicz J, Frankiewicz L, Novoa A, Bochynska M, Keresztes A, Kosson P, Makuch W, Van Duppen J, Chung NN, Vanden Broeck J, Lipkowski AW, Schiller PW, Janssens F, Ceusters M, Sommen F, Meert T, Przewlocka B, Tourwé D, Ballet S.

ACS Med Chem Lett. 2015 Oct 31;6(12):1209-14. doi: 10.1021/acsmedchemlett.5b00359. eCollection 2015 Dec 10.

25.

Pharmacological kynurenine 3-monooxygenase enzyme inhibition significantly reduces neuropathic pain in a rat model.

Rojewska E, Piotrowska A, Makuch W, Przewlocka B, Mika J.

Neuropharmacology. 2016 Mar;102:80-91. doi: 10.1016/j.neuropharm.2015.10.040. Epub 2015 Oct 31.

PMID:
26524415
26.

PD98059 Influences Immune Factors and Enhances Opioid Analgesia in Model of Neuropathy.

Rojewska E, Popiolek-Barczyk K, Kolosowska N, Piotrowska A, Zychowska M, Makuch W, Przewlocka B, Mika J.

PLoS One. 2015 Oct 1;10(10):e0138583. doi: 10.1371/journal.pone.0138583. eCollection 2015.

27.

Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats.

Kwiatkowski K, Piotrowska A, Rojewska E, Makuch W, Jurga A, Slusarczyk J, Trojan E, Basta-Kaim A, Mika J.

Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4;64:68-78. doi: 10.1016/j.pnpbp.2015.07.005. Epub 2015 Jul 16.

PMID:
26190414
28.

Parthenolide Relieves Pain and Promotes M2 Microglia/Macrophage Polarization in Rat Model of Neuropathy.

Popiolek-Barczyk K, Kolosowska N, Piotrowska A, Makuch W, Rojewska E, Jurga AM, Pilat D, Mika J.

Neural Plast. 2015;2015:676473. doi: 10.1155/2015/676473. Epub 2015 May 18.

29.

IL-1 receptor antagonist improves morphine and buprenorphine efficacy in a rat neuropathic pain model.

Pilat D, Rojewska E, Jurga AM, Piotrowska A, Makuch W, Przewlocka B, Mika J.

Eur J Pharmacol. 2015 Oct 5;764:240-8. doi: 10.1016/j.ejphar.2015.05.058. Epub 2015 Jun 1.

PMID:
26043968
30.

Effects of chronic doxepin and amitriptyline administration in naïve mice and in neuropathic pain mice model.

Mika J, Jurga AM, Starnowska J, Wasylewski M, Rojewska E, Makuch W, Kwiatkowski K, Malek N, Przewlocka B.

Neuroscience. 2015 May 21;294:38-50. doi: 10.1016/j.neuroscience.2015.03.003. Epub 2015 Mar 10.

PMID:
25769941
31.

A multi-target approach for pain treatment: dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis.

Malek N, Mrugala M, Makuch W, Kolosowska N, Przewlocka B, Binkowski M, Czaja M, Morera E, Di Marzo V, Starowicz K.

Pain. 2015 May;156(5):890-903. doi: 10.1097/j.pain.0000000000000132. Erratum in: Pain. 2015 Jul;156(7):1370.

PMID:
25719612
32.

Synthesis and biological evaluation of compact, conformationally constrained bifunctional opioid agonist - neurokinin-1 antagonist peptidomimetics.

Guillemyn K, Kleczkowska P, Lesniak A, Dyniewicz J, Van der Poorten O, Van den Eynde I, Keresztes A, Varga E, Lai J, Porreca F, Chung NN, Lemieux C, Mika J, Rojewska E, Makuch W, Van Duppen J, Przewlocka B, Vanden Broeck J, Lipkowski AW, Schiller PW, Tourwé D, Ballet S.

Eur J Med Chem. 2015 Mar 6;92:64-77. doi: 10.1016/j.ejmech.2014.12.033. Epub 2014 Dec 19.

33.

The influence of microglia activation on the efficacy of amitriptyline, doxepin, milnacipran, venlafaxine and fluoxetine in a rat model of neuropathic pain.

Zychowska M, Rojewska E, Makuch W, Przewlocka B, Mika J.

Eur J Pharmacol. 2015 Feb 15;749:115-23. doi: 10.1016/j.ejphar.2014.11.022. Epub 2014 Nov 25.

PMID:
25460025
34.

Involvement of pro- and antinociceptive factors in minocycline analgesia in rat neuropathic pain model.

Rojewska E, Popiolek-Barczyk K, Jurga AM, Makuch W, Przewlocka B, Mika J.

J Neuroimmunol. 2014 Dec 15;277(1-2):57-66. doi: 10.1016/j.jneuroim.2014.09.020. Epub 2014 Oct 2.

35.

Minocycline enhances the effectiveness of nociceptin/orphanin FQ during neuropathic pain.

Popiolek-Barczyk K, Rojewska E, Jurga AM, Makuch W, Zador F, Borsodi A, Piotrowska A, Przewlocka B, Mika J.

Biomed Res Int. 2014;2014:762930. doi: 10.1155/2014/762930. Epub 2014 Sep 3.

36.

Minocycline prevents dynorphin-induced neurotoxicity during neuropathic pain in rats.

Rojewska E, Makuch W, Przewlocka B, Mika J.

Neuropharmacology. 2014 Nov;86:301-10. doi: 10.1016/j.neuropharm.2014.08.001. Epub 2014 Aug 27.

37.

Inhibition of intracellular signaling pathways NF-κB and MEK1/2 attenuates neuropathic pain development and enhances morphine analgesia.

Popiolek-Barczyk K, Makuch W, Rojewska E, Pilat D, Mika J.

Pharmacol Rep. 2014 Oct;66(5):845-51. doi: 10.1016/j.pharep.2014.05.001. Epub 2014 May 19.

PMID:
25149989
38.

Delta-opioid receptor analgesia is independent of microglial activation in a rat model of neuropathic pain.

Mika J, Popiolek-Barczyk K, Rojewska E, Makuch W, Starowicz K, Przewlocka B.

PLoS One. 2014 Aug 8;9(8):e104420. doi: 10.1371/journal.pone.0104420. eCollection 2014.

39.

Analgesic effects of antidepressants alone and after their local co-administration with morphine in a rat model of neuropathic pain.

Jagla G, Mika J, Makuch W, Obara I, Wordliczek J, Przewlocka B.

Pharmacol Rep. 2014 Jun;66(3):459-65. doi: 10.1016/j.pharep.2013.11.004. Epub 2014 Apr 3.

PMID:
24905524
40.

Neuronal and immunological basis of action of antidepressants in chronic pain - clinical and experimental studies.

Mika J, Zychowska M, Makuch W, Rojewska E, Przewlocka B.

Pharmacol Rep. 2013;65(6):1611-21. Review.

41.

The effects of early-life adversity on fear memories in adolescent rats and their persistence into adulthood.

Chocyk A, Przyborowska A, Makuch W, Majcher-Maślanka I, Dudys D, Wędzony K.

Behav Brain Res. 2014 May 1;264:161-72. doi: 10.1016/j.bbr.2014.01.040. Epub 2014 Feb 4.

PMID:
24508235
42.

Effects of selective and non-selective inhibitors of nitric oxide synthase on morphine- and endomorphin-1-induced analgesia in acute and neuropathic pain in rats.

Makuch W, Mika J, Rojewska E, Zychowska M, Przewlocka B.

Neuropharmacology. 2013 Dec;75:445-57. doi: 10.1016/j.neuropharm.2013.08.031. Epub 2013 Sep 10.

PMID:
24035921
43.

Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism.

Starowicz K, Makuch W, Korostynski M, Malek N, Slezak M, Zychowska M, Petrosino S, De Petrocellis L, Cristino L, Przewlocka B, Di Marzo V.

PLoS One. 2013;8(4):e60040. doi: 10.1371/journal.pone.0060040. Epub 2013 Apr 3.

44.

Spinal anandamide produces analgesia in neuropathic rats: possible CB(1)- and TRPV1-mediated mechanisms.

Starowicz K, Makuch W, Osikowicz M, Piscitelli F, Petrosino S, Di Marzo V, Przewlocka B.

Neuropharmacology. 2012 Mar;62(4):1746-55. doi: 10.1016/j.neuropharm.2011.11.021. Epub 2011 Dec 8.

PMID:
22178705
45.

The effect of botulinum neurotoxin A on sciatic nerve injury-induced neuroimmunological changes in rat dorsal root ganglia and spinal cord.

Mika J, Rojewska E, Makuch W, Korostynski M, Luvisetto S, Marinelli S, Pavone F, Przewlocka B.

Neuroscience. 2011 Feb 23;175:358-66. doi: 10.1016/j.neuroscience.2010.11.040. Epub 2010 Nov 25.

PMID:
21111791
46.

Botulinum neurotoxin type A counteracts neuropathic pain and facilitates functional recovery after peripheral nerve injury in animal models.

Marinelli S, Luvisetto S, Cobianchi S, Makuch W, Obara I, Mezzaroma E, Caruso M, Straface E, Przewlocka B, Pavone F.

Neuroscience. 2010 Nov 24;171(1):316-28. doi: 10.1016/j.neuroscience.2010.08.067. Epub 2010 Sep 6.

PMID:
20826198
47.

Minocycline reduces the injury-induced expression of prodynorphin and pronociceptin in the dorsal root ganglion in a rat model of neuropathic pain.

Mika J, Rojewska E, Makuch W, Przewlocka B.

Neuroscience. 2010 Feb 17;165(4):1420-8. doi: 10.1016/j.neuroscience.2009.11.064. Epub 2009 Dec 1.

PMID:
19961904
48.

Glial inhibitors influence the mRNA and protein levels of mGlu2/3, 5 and 7 receptors and potentiate the analgesic effects of their ligands in a mouse model of neuropathic pain.

Osikowicz M, Skup M, Mika J, Makuch W, Czarkowska-Bauch J, Przewlocka B.

Pain. 2009 Dec 15;147(1-3):175-86. doi: 10.1016/j.pain.2009.09.002. Epub 2009 Sep 25.

PMID:
19782473
49.

Local peripheral opioid effects and expression of opioid genes in the spinal cord and dorsal root ganglia in neuropathic and inflammatory pain.

Obara I, Parkitna JR, Korostynski M, Makuch W, Kaminska D, Przewlocka B, Przewlocki R.

Pain. 2009 Feb;141(3):283-91. doi: 10.1016/j.pain.2008.12.006. Epub 2009 Jan 14.

PMID:
19147290
50.

Attenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice.

Mika J, Wawrzczak-Bargiela A, Osikowicz M, Makuch W, Przewlocka B.

Brain Behav Immun. 2009 Jan;23(1):75-84. doi: 10.1016/j.bbi.2008.07.005. Epub 2008 Jul 22.

PMID:
18684397

Supplemental Content

Loading ...
Support Center